Research

The Bocarsly Lab uses a systems level approach to identify the neural substrates, circuits, and behavioral motivations driving food intake and their contributions to the development of disease states such as compulsive overeating, obesity, and anorexia. To do this, the laboratory uses a combination of novel transgenic mouse lines, optogenetics, chemogenetics, in vivo fiber photometry, molecular techniques, ex vivo brain slice fast-scan cyclic voltammetry, and fiber photometry, as well as behavior using mouse models.

Central Insulin Sensitivity Augmented by Semaglutide in Obese Male Mice


GLP-1 receptor agonist semaglutide has been shown to regulate feeding behaviors for substantial weight loss. Treated patients and animal models demonstrate changes in the regulation of dopamine transmission in the striatum. We are investigating insulin signaling as a mechanism for central satiation signaling in the dorsal and ventral striatum through increased evoked dopamine concentrations.


The role of high-fat diet consumption on emotion like-behaviors and dopamine circuitry in the amygdala

 

This project utilizes animal models to examine the link between dietary fat intake and the development of mental health disorders with the goal of elucidating neuronal circuitry in the amygdala. We are using behavioral assessments, voltammetry, chemogenetics tools, qPCR, and ELISA assays.

Evaluating the Role of ApoE4 on Insulin Resistance in Alzheimer’s Disease


Alzheimer’s disease is the most common neurodegenerative disorder, and the apolipoprotein E4 (ApoE4) allele has been identified as the strongest genetic risk factor for AD. The scope of ApoE4's contribution to Alzheimer's remains unclear, but research suggests that it may cause impaired neuronal insulin signaling and insulin resistance. Using both in-vitro and in-vivo studies,  we investigate the role of ApoE4 in Alzheimer's pathology by determining its impact on insulin signaling and identifying possible therapeutic strategies.  

Dopamine D3 receptors in the striatum and their involvement in behaviors in obesity and addiction

Using novel transgenic mice, stereotaxic surgery, and behavioral interventions we are evaluating the role of the dopamine D3 receptor and its role in obesity and addiction phenotypes. Through further investigation we hope to elucidate the effect that the D3R plays in these behaviors and contribute towards future interventions.

Dopamine D2 receptors in the lateral hypothalamus and their role in dysregulated feeding

Obesity poses a growing public health issue, and it is becoming increasingly evident that this addictive state of eating may be associated with dysregulation in dopaminergic reward pathways. Using transgenic mice and stereotaxic surgery, we investigate the role of the dopamine D2 receptor in the lateral hypothalamus, the "feeding center" of the brain. 

Olanzapine induced modifications to neuroinflammation and dopamine metabolism in Schizophrenia

Utilizing a high risk schizophrenia mouse model, we are researching dopamine metabolism and neuroinflammation in the striatum of mice brains. We are also looking into alterations that are occurring with long-term Olanzapine treatment in the same mouse model. 

Identifying a novel approach to stress-induced eating in transgenic mice

Individuals experiencing stressful circumstances often turn to increased food consumption as a coping mechanism. There exists the potential of this seemingly harmless strategy turning into an addictive behavior. We seek to understand if this perceived stress-eating can be characterized through behavioral and biological means. 

It is also fundamental to our research to understand dopamine signaling pathways in the striatum, as they play an integral role in feeding. In order to further investigate the role of dopamine receptors and their link to stress-induced feeding behaviors, transgenic mouse models with a knockdown of dopamine D2 receptors are used.